Successful Lung Transplantation for Pulmonary Disease Associated With Erdheim-Chester Disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 28633251.
- Also identified by DOI 10.1016/j.athoracsur.2017.02.020.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 53-year-old man with pulmonary fibrosis associated with Erdheim-Chester disease achieved long-term survival after lung transplantation. Major clinical manifestations included lung and bone injuries, and other vital organs were functionally unaffected by the disease. After a careful observation for the disease progression, he underwent bilateral deceased-donor lung transplantation. He has returned to his normal social life and is doing well without recurrence of Erdheim-Chester disease in the lung allograft or progression in other organs 5 years after transplant. Lung transplantation is a potentially reasonable treatment option for Erdheim-Chester disease involving the lungs if the functions of other vital organs remain stable.
Medical subject headings
- Erdheim-Chester Disease
- Lung
- Lung Transplantation
- Pulmonary Fibrosis